Seminar Details
Myotonic dystrophy type 1 (DM1) is caused by an expanded CTG repeat, which leads to missplicing in many organs including skeletal muscle, heart and brain. People affected with DM1 experience muscle weakness and wasting, cardiac arrhythmia and excessive fatigue. Our translational program develops innovative biomarkers and treatments for DM1, which has it’s highest prevalence worldwide in Eastern Canada.
Dr. Hanns Lochmüller
MD, PhD
Professor, Associate Scientist, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, Senior Scientist, CHEO Research Institute
Accessibility
If you require accommodation, please contact the event host as soon as possible.